explore -WSS

explore

author：entertainment 2025-10-01 23:07:03 - browse：586

A clipboard with checklist on blue dark background. -- health tech coverage from STAT — Adobe

A Pittsburgh artificial intelligence startup emerging as a challenger to Microsoft’s clinical note taking business has raised $150 million, a rare mega deal in a funding lull. The startup, Abridge, also has an unlikely cheerleader: Paul Ricci, the former head of Nuance, the service from Microsoft it competes with.

Abridge sells an AI tool that rapidly transcribes and summarizes doctors’ conversations with patients in a hospital’s electronic health records software. The startup’s leaders and investors tell STAT they’re betting that their medical knowledge, agility, and willingness to co-develop features with customers makes it a more attractive long term option than Nuance, which Microsoft says is currently used by most U.S. hospitals.

Microsoft, Abridge and other startups like Suki, Corti and Nabla are locked in a race to ease provider burnout by automating clinical note taking, and — thanks to generative AI — organizing the data in a way that could improve care, such as suggesting topics for follow-up, simplifying billing or analyzing trends at the broader patient population level.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

hotspot

WSS

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Bird flu: Don't repeat Covid's 'health versus the economy' framing

When prostate cancer spreads, where it goes matters

Biogen walks away from Aduhelm, years after polarizing approval

explore

explore

hotspot

Peter Hotez and the public health issue of online harassment

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Affirmative action in medical school literally saved lives

Boston competes with Raleigh

Activists slam private health insurers over coverage restrictions

Criminal prosecution for violating HIPAA: an emerging threat

Medical records are filled with copy

With measles on the rise, a personal story of a devastating disease

Activists slam private health insurers over coverage restrictions

HIV vaccine remains elusive. Immunologists keep trying new ideas

focus

Helping hospitals and community health centers plan for resilience

10 reasons why health care startups fail

Arc Institute generative AI designs new CRISPR systems

Wearables generate powerful data but its not useful to doctors, yet

Big Tobacco's 'harm reduction': Is it for real, or a sham?

10 reasons why health care startups fail

hotspot

entertainment

focus

knowledge